Facebook

Twitter

Dribble

Facebook

1312 POSTS

☰

Post Count: 158

Health Analysis

What is the difference between a Markov and semi-Markov model? – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - September 16, 2025

The free online book R for Health Technology Assessment has the answer:

Markov models are characterised by a memoryless property called the Markov assumption or Markov property. Under.

TAGS: #difference#Economist#Healthcare#Markov#model#semiMarkov

Why Nations Fail – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - September 15, 2025

Recently I read the book Why Nations Fail: The Origins of Power, Prosperity and Poverty by Daron Acemoglu and James A. Robinson. Why nations fail is of course is a very.

Caregiver risk preferences for delaying loss of ambulation in Duchenne muscular dystrophy – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - September 4, 2025

That is the title of a paper published today in Current Medical Research and Opinion with co-authors Nadine Zawadzki, Moises Marin, Ivana Audhya, Lauren Sedita, Natasha Kulkarni and.

How often does FDA use expedited regulatory pathway for oncology drugs? – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - September 2, 2025

FDA uses expedited regulatory pathways (ERPs) in order to accelerate the availability of drugs and diagnostic tests for severe conditions that have unmet medical needs. How often.

CMMI’s New Strategic Direction – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - August 26, 2025

The Center for Medicare and Medicaid Innovation (CMMI) recently released a new strategy to “Make America Healthy Again.” The strategy includes:

Promoting evidence-based prevention
Empowering people to achieve their health goals
Driving.

TAGS: #CMMIs#Direction#Economist#Healthcare#Strategic

Will most favored nation reduce drug prices in the US…or raise prices in Europe? – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - August 17, 2025

The answer seems to be the latter. The Times (UK) reports.

Eli Lilly, the US-based manufacturer of Mounjaro, said it was hiking the UK list.

TAGS: #drug#Economist#Europe#Favored#Healthcare#Nation#prices#raise#reduce#USor

Quotation of the Day – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - August 10, 2025

There is only one difference between a bad economist and a good one: the bad economist confines himself to the visible effect; the good economist takes into account both the.

TAGS: #Day#Economist#Healthcare#Quotation

Are prices driving increases in Medicare spending? Even so, can the government set ‘good’ prices? – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - August 7, 2025

According to a recent Health Affairs Perspective from Michael Chernew, the answer is ‘no’. In fact, physician and hospital prices may be too low.

Although much.

TAGS: #driving#Economist#good#government#Healthcare#increases#Medicare#prices#set#spending

What’s in the UK’s Life Sciences Sector Plan? – Healthcare Economist

DiagnosticTest.Pro - Health Analysis - July 21, 2025

Yesterday, the UK government released it’s Life Sciences Sector Plan (LSSP). The British government summarized the provisions as follows:

1. Unlocking NHS data to find new cures. Up to £600.

TAGS: #Economist#Healthcare#life#Plan#Sciences#Sector#UKs#Whats

Scroll To Top